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Abstract
Background: Staphylococcal (or micrococcal) nuclease or thermonuclease (SNase or Nuc) is a naturally-secreted 
nucleic acid degrading enzyme that participates in Staphylococcus aureus spread in the infected host. Purified Nuc 
protein can be used as an exogenous reagent to clear cellular extracts and improve protein purification. Here, a 
recombinant form of Nuc was produced and secreted in a Gram-positive host, Lactococcus lactis, and purified from the 
culture medium.
Results: The gene segment corresponding to the S. aureus nuclease without its signal peptide was cloned in an 
expression-secretion vector. It was then fused to a lactococcal sequence encoding a signal peptide, and expressed 
under the control of a lactococcal promoter that is inducible by zinc starvation. An L. lactis subsp cremoris model strain 
(MG1363) transformed with the resulting plasmid was grown in either of two media (GM17v and CDM) that are free of 
animal compounds, allowing GMP (Good Manufacturing Practice) production. Induction conditions (concentration of 
the metal chelator EDTA and timing of addition) in small-scale pH-regulated fermentors were optimized using LacMF 
(Lactis Multi-Fermentor), a home-made parallel fermentation control system able to monitor 12 reactors 
simultaneously. Large amounts of recombinant Nuc (rNuc) were produced and secreted in both media, and rNuc was 
purified from GM17v medium in a single-step procedure.
Conclusions: In L. lactis, rNuc production and secretion were optimal after induction by 0.5 mM EDTA in small scale 
(200 mL) GM17v exponential phase cultures (at an OD600 of 2), leading to a maximal protein yield of 210 mg per L of 
culture medium. Purified rNuc was highly active, displaying a specific activity of 2000 U/mg.
Background
L. lactis which is widely used as a starter in dairy indus-
tries, is also an efficient cell factory for the production
and secretion of proteins [1]. i) Proteins produced in this
species, which is considered as safe by virtue of its long-
time human consumption, should obtain the GRAS
(Generally Recognized As Safe) status and be suitable for
therapeutical or vaccine applications [1], in contrast to
proteins produced in Escherichia coli from which endo-
toxin (LPS) has to be removed [2]. ii) In this Gram+ spe-
cies, the secretion of any heterologous protein fused to an
appropriate signal peptide can be easily and efficiently
driven by the general export (Sec) pathway [1], thus
avoiding potential intra-cellular toxicity and/or misfold-
ing. iii) In this species, an extracellular protease-free
strain (without the unique surface protease HtrA [3]) is a
useful host to avoid protein degradation [4], whereas in
Bacillus subtilis, not all extracellular proteases have been
inactivated to date (4 active surface proteases, including
the 3 HtrA family members, are remaining in the avail-
able mutant strains) [5,6]. iv) Only one major protein,
Usp45, is secreted in significant amounts into the
medium [7], thus facilitating downstream purification
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steps. v) Finally, setting up conditions for protein produc-
tion in large fermentors should be easy as culture scale-
up is linear [8].
In this context, several gene expression systems have
been developed for L. lactis: i) NICE, the most widely
used system based on the PnisA promoter and nisRK two-
component regulatory system, is induced by nisin [9]; ii)
P170, which is regulated by RcfB, is induced by lactic
acid, in particular during the transition to the stationary
phase of growth where the pH is low due to lactate accu-
mulation [10,11] (SM Madsen, personal communication),
and iii) PZn is tightly regulated by the ZitR repressor in
response to extra-cellular Zn2+ levels: it is repressed in a
wide concentration range from repletion to toxicity, and
induced by starvation [12-14] (Daniel Llull, Olivier Son,
Nicolas Trémillon, Sandrine Blanié, Julien Briffotaux,
Sébastien Blugeon, Eric Morello, Hélène Rogniaux,
Olivier Danot, and Isabelle Poquet: ZitR, a prototype of a
new class of zinc responsive repressors in Streptococca-
ceae, submitted). As an expression system, ZitR-regulated
PZn should allow the repression of a potentially toxic het-
erologous ORF in the presence of Zn2+ (e. g. in a rich
medium), and once a sufficient amount of biomass has
been obtained, its induction by addition of a chelator
agent (e. g. EDTA) [12,14]. To allow protein secretion,
expression systems have been combined with several sig-
nal peptides: i) that of Usp45 [1,7] ii) that of Exp4
[13,15,16], and iii) several optimized signal peptides
(SP310 series) [17,18].
Finally, with the use of all available tools, L. lactis has
proved to be an efficient host for the production and
secretion of proteins of medical interest, generally in
flasks for laboratory studies [1], but also in small scale
(1L) fermentors [17]. Recently, the lysostaphin from
Staphylococcus simulans biovar staphylolyticus was suc-
cessfully produced at the industrial scale (3000 L) in L.
lactis using the NICE system. Surprisingly though, this
naturally-secreted protein was produced as a recombi-
nant signal peptide-free form that had to be purified from
the lactococcal cell extract [8,19].
In the present study, the efficiency of L. lactis as a host
for heterologous protein production and secretion, and
the ease of protein purification from a lactococcal culture
medium were evaluated using the staphylococcal nucle-
ase Nuc [20,21] as a model protein of biotechnological
and commercial interest. Nuc is a robust exo- and endo-
5'-phosphodiesterase (EC 3.1.31.1) active against both
DNA and RNA [22-24]. It can be used for RNA sequenc-
ing [25] and in several applications where nucleic acid
removal is desired, like reduction of the viscosity of a cell
lysate, improvement of protein purification, and develop-
ment of in vitro translation systems [26-28]. In S. aureus,
Nuc participates in the spread of the bacterial cells in the
infected host [29] as a naturally-secreted enzyme: cleav-
age of the precursor signal peptide leads to the secretion
of the pro-peptide form (NucB) that is processed to the
mature form (NucA) [30]. Different forms of Nuc protein
have been produced in several species: the native wild-
type form, in Bacillus subtilis [31], Corynebacterium glu-
tamicum [32] and L. lactis [33], and recombinant forms
fused to different signal peptides, in E. coli [26,34] and in
L. lactis [ 1 6 , 3 5 ]  w h e r e  N u c B  p r o c e s s i n g  t o  N u c A  w a s
found to require HtrA protease [3,36].
In this study, a recombinant Nuc form (rNuc) was suc-
cessfully produced and secreted in L. lactis using a
recently developed expression-secretion system [13] and
small-scale pH-regulated reactors. An active rNuc pro-
tein could be purified in a single step from the culture
medium, indicating that secretion is a good method for
facilitating the purification of a heterologous protein pro-
duced in L. lactis.
Results
Expression-secretion vector
pGTP_FZ301 (Figure 1A) is an expression and secretion
vector for L. lactis that is derived from pLB145 [13].
pGTP_FZ301 enables any ORF to be cloned as a transla-
tional fusion to the lactococcal sequence encoding Exp4
signal peptide [15,16], and the fusion and zitR constitute
an operon under the control of the PZn promoter [12].
The cloning of nucB  ORF (encoding NucB form) into
pGTP_FZ301 resulted in pGTP_FZ301_NucB, and led to
the production of a recombinant precursor that is
secreted as rNuc (Figure 1B). This recombinant protein
was designed because the wild-type Nuc precursor which
bears an atypical signal peptide is not efficiently secreted
in L. lactis [33], in contrast to a fusion between NucB and
a lactococcal signal peptide [35].
Optimization of induction conditions
For rNuc production in L. lactis subsp cremoris strain 918
[MG1363(pGTP_FZ301_NucB)], a new medium was
developed. This rich medium is free of animal com-
pounds (GM17v), which could prove useful for the pro-
duction of proteins that must be devoid of any potentially
pathogenic contaminant, such as therapeutic proteins. In
pH-regulated cultures using GM17v, a final OD600 of 15-
16 could be reached (Figure 2).
The induction parameters of GM17v cultures were
optimized taking previously published data about the lac-
tococcal fermentation process [19] and induction condi-
tions of ZitR-regulated PZn in other media ([12] and data
not shown) into account. Optimization was achieved
using LacMF, a parallel fermentation control system able
to monitor 12 mini-reactors simultaneously (Additional
file 1, Figure S1).Trémillon et al. Microbial Cell Factories 2010, 9:37
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To determine the PZn induction conditions in GM17v,
different concentrations of the metal chelator EDTA were
added to cultures in different growth phases. Both cell
growth and rNuc secretion in the medium were moni-
tored (Figure 2). Before induction, the rNuc protein was
undetectable in mid-exponential phase cultures (for
uninduced cells at an OD600 of 2 or 4, data not shown and
Figures 2A and 2B), and present in low amounts for late-
exponential/stationary phase cultures (5 mg/L for unin-
duced cells at an OD600 of 8, Figure 2A). This result sug-
gested that the PZn promoter was first repressed and then
progressively induced during growth in GM17v medium,
probably because extra-cellular Zn2+ became depleted, as
previously observed in another rich medium, GM17 (data
not shown), and in a chemically defined medium [12]
(Daniel Llull, Olivier Son, Nicolas Trémillon, Sandrine
Blanié, Julien Briffotaux, Sébastien Blugeon, Eric Morello,
Hélène Rogniaux, Olivier Danot, and Isabelle Poquet:
ZitR, a prototype of a new class of zinc responsive repres-
sors in Streptococcaceae, submitted).
When added at 1 mM at an OD600 of 2 (Figure 2A) or
below (data not shown), EDTA impaired growth which
stopped as early as one generation after addition. When 1
mM EDTA was added at an OD600 of 4 or 8, the growth
impairment seemed to be weaker, probably because late
or post-exponential phase cells could almost reach the
growth plateau after exposure to the inducer (Figure 2A).
The time of induction had a significant effect on the level
of rNuc in the medium. Induction before the OD600
reached 2 severely impaired growth and consequently
low rNuc levels were obtained (data not shown). In con-
trast, when EDTA was added at an OD600 of 2 or above,
rNuc accumulated rapidly within the first hour of induc-
tion, and a high final level of between 100 and 200 mg/L
was reached. The optimum of 200 mg/L was obtained for
induction at OD600 4 (Figure 2A).
In a second phase of optimization, different concentra-
tions of EDTA were added at an OD600 of 2 (Figure 2B).
Whereas EDTA at 1 mM (Figure 2A) or above (data not
shown) severely impaired growth, little (a slightly
reduced OD600 at the plateau) or no growth defect was
observed for 500 μM or 100 μM EDTA (Figure 2B). rNuc
production in the medium significantly varied with the
inducer concentration. After induction with 100 μM
EDTA, the rNuc level followed growth and reached its
maximum only at the growth plateau, whereas higher
EDTA concentrations led a drastic rNuc accumulation
within the first hour of induction (Figure 2B) followed by
a slight further augmentation afterwards. Interestingly,
the fast kinetics of accumulation was not related to a
growth defect as it could be observed for either 500 μM
EDTA (Figure 2B) or 1 mM EDTA (Figure 2A). 500 μM
was found to be the optimal inducer concentration when
Figure 1 Expression-secretion vector used for rNuc production. (A) pGTP_FZ_301 allows any open reading frame to be cloned as a translational 
fusion to Exp4 signal peptide coding sequence, and expressed as an operon to zitR under the control of PZn promoter. (B) pGTP_FZ_301_NucB results 
from the cloning of a recombinant truncated form of S. aureus nuc ORF (coding for NucB) into pGTP_FZ_301. NucB, the secreted mature form of staph-
ylococcal Nuc (after signal peptide cleavage) is fused in frame to Exp4 signal peptide, leading to a recombinant precursor that is secreted as rNuc. 
MCS: Multi-Cloning Site; RBS: Ribosome Binding Site; term: terminator
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added at OD600 2 and allowed rNuc production to reach a
level of 200 mg/L.
As these results indicated that (i) both time of induc-
tion (OD600) and EDTA concentration were important
parameters for rNuc production, and that (ii) rNuc con-
tinued accumulating untill the growth plateau was
reached (albeit sometimes slowly), the combined effect of
both parameters on final rNuc levels after prolonged cul-
tures was monitored (Figure 2C). rNuc increased in
direct proportion to the EDTA concentration up to 500
μM. Above 1 mM EDTA, rNuc production did not
improve regardless of the OD600 at which EDTA was
added (Figure 2C). The maximal concentration of rNuc in
the medium, 210 mg/L, was obtained when 500 μM
EDTA was added to cells at an OD600 of 2 (Figures 2B and
2C), thus defining the optimal conditions for rNuc pro-
duction and secretion in lactococcal cultures grown in
GM17v.
In a second set of experiments, two media, the previ-
ously-used rich medium, GM17v, and a chemically
defined medium, CDM [37], were compared. Interest-
ingly, the induction conditions optimised for GM17v
medium were applicable to CDM and allowed production
of rNuc to comparable levels (Figure 3).
Figure 2 Optimization of induction conditions for maximal rNuc production. Cultures of strain 918 grown in GM17v using LacMF were induced 
by the addition of EDTA at different time points (A) or concentrations (B) or both (C). In (A) and (B), both bacterial growth (solid lines) and rNuc con-
centration into the medium (dotted lines, calculated by comparison to a quantified standard on stained gels) are shown as a function of time (￿ indi-
cates EDTA addition time point). As before induction, rNuc level was undetectable for mid-exponential phase cultures (at OD600 2 and 4), an arbitrary 
value (1 mg/L, corresponding to the sensitivity threshold of our staining method) is indicated (black star). (A) rNuc levels as a function of time after 
induction of a culture at different growth stages by highly concentrated EDTA. 1 mM EDTA was added or not (black square) to parallel cultures at 
different OD600, i. e. 2 (black diamond), 4 (black circle) or 8 (X). (B) rNuc level as a function of time after induction of an exponential phase culture by 
EDTA at different concentrations. Cultures at OD600 2 were induced or not (black square) by EDTA at various concentrations: 100 μM (black triangle), 
500 μM (upside down black triangle) or 1 mM (black diamond). (C) Final rNuc level as a function of both induction OD600 and EDTA concentration. 
Final rNuc concentration in the medium after prolonged growth (8 h-9 h of culture) is shown.
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One-step Purification and nuclease activity
rNuc produced and secreted by strain 918 at the highest
level (after induction of cells grown in GM17v to an
OD600 of 2 by 500 μM EDTA) was purified from the cul-
ture medium using a simple, previously-described single
step procedure [38]. This procedure, based on cation
exchange chromatography, excludes Usp45, the main
secreted lactococcal protein [7] (Figure 4). Approximately
85% of rNuc could be recovered from the culture super-
natant by this method (data not shown), and finally, ultra-
pure rNuc (> 99%) concentrated at 115 mg/L (as
determined by SDS-PAGE analysis using Bovine Serum
Albumin (BSA) as a standard) was obtained. Nuclease
activity on denatured DNA was assayed as previously
described [22,23], showing that purified rNuc exhibited a
high specific enzymatic activity of 2000 U/mg (for com-
parison, this is 7-20 times higher than a marketed Nuc
protein [39]).
Discussion
To determine the conditions for the use of L. lactis to pro-
duce a secreted heterologous protein, we chose the staph-
ylococcal nuclease, a protein used in the field of
biotechnology. This nucleic acid degrading enzyme can
be used in several applications, particularly protein puri-
fication, by reducing the viscosity of a cell lysate [26,27]
and the nucleic acid contamination of the protein which,
in the specific case of therapeutic proteins, is required by
FDA to be less than 100 pg per dose [40].
A new system for the production of recombinant pro-
teins was developed. As a cell factory, we used L. lactis
grown in either a new, rich and animal compound-free
medium (GM17v) or a chemically defined medium
(CDM). The heterologous ORF was cloned in
pGTP_FZ301 vector under the control of PZn and fused to
the sequence encoding the Exp4 signal peptide, and its
expression was induced by the chelator EDTA. The whole
production-secretion system should be fully compatible
with regulatory restrictions in bioproduction for human
therapeutics, and the proteins produced with it should be
considered as GRAS products. Alternatively, L. lactis
grown in CDM medium might also be an interesting host
system for specific amino acid labelling (C13, N15, seleno-
methionine or seleno-cysteine) and protein structural
studies through NMR or X-Ray crystallography.
For cell growth, a pH-regulated batch fermentation
process was used. Using a parallel fermentation control
system (LacMF), the pH value was maintained at the set
point by the addition of a mild alkaline agent, NH4OH. It
was previously shown that pH neutralization leads to
prolonged exponential growth of L. lactis and increases
the final cell density about fivefold compared with pH-
unregulated batch culture fermentation [17,19]. Indeed,
the biomass of pH-regulated cultures reached high levels
(final OD600 of around 15-16, Figures 2 and 3). NH4OH
addition also maintains lactic acid in its dissociated lac-
ta t e  f orm  whi c h is  less-t o xic [ 41]  eve n t hough a t  high
concentrations, it also slows growth [42]. To further
increase the productivity of the expression system used
here, lactate [43,44] should be continuously extracted
using continuous perfusion [45] (unpublished results)
and electro-dialysis (i. e. REED) [46]. The latter technol-
ogy with lactococcal expression system P170, allowed to
reach protein yields in the gram per liter range [47].
Medium composition could also be optimized, as the
addition of nitrogen and carbon sources was previously
found to significantly increase protein production in L.
lactis grown in a rich medium [19].
LacMF was a useful tool to optimize EDTA induction
in L. lactis. The best way to induce the PZn promoter was
to add a non-toxic concentration of EDTA to an exponen-
tial phase culture, in agreement with what had previously
been observed in another medium [12]. Induction in the
exponential phase should maximize the effective produc-
tion period before the stationary phase and toxic lactate
accumulation.
Figure 3 rNuc production as a function of the culture medium. 
Strain 918 was grown in either GM17v (A) or CDM (B) till an OD600 of 2, 
and induced or not (black square) by addition of 500 μM EDTA (black 
triangle). Culture growth and rNuc concentration in the medium are 
indicated by solid or dotted lines respectively. The induction time 
point and undetectable levels of rNuc (<1 mg/L, see Figure 2 Legend) 
are respectively indicated by ￿ and (black star) symbols.
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Figure 4 Purification of secreted rNuc protein by cationic exchange chromatography. (A) Ion exchange chromatogram for rNuc purified from 
the supernatant of strain 918 grown in GM17v. NaCl concentration (brown line) and absorption at 280 nm (blue line) are shown. Fractions analysed 
by SDS-PAGE are indicated by grey bars underneath. (B) SDS-PAGE analysis of different fractions (E2-11) of the cationic exchange chromatography 
stained by Coomassie brilliant Blue. MW: Molecular Weight Marker, D: Diluted culture supernatant, FT: Flow Through, W: Washing, E1-12: Elution frac-
tions number 1-12. Secreted rNuc protein (after signal peptide cleavage by signal peptidase) and the mature NucA form (resulting from pro-peptide 
processing by HtrA surface protease, as previously observed [3]), are indicated by arrows.
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In the absence of induction, rNuc is first undetectable
when produced by exponentially growing cells, suggest-
ing that its expression is repressed, and then weakly
induced in late-exponential/stationary phase cells (Fig-
u r e s  2 A  a n d  2 B ) ,  a s  p r e v i o u s l y  o b s e r v e d  i n  a n o t h e r
medium [12] (Daniel Llull, Olivier Son, Nicolas Trémill-
on, Sandrine Blanié, Julien Briffotaux, Sébastien Blugeon,
Eric Morello, Hélène Rogniaux, Olivier Danot, and Isa-
belle Poquet: ZitR, a prototype of a new class of zinc
responsive repressors in Streptococcaceae, submitted).
This growth-phase dependent regulation suggests that
free Zn2+, initially present in the medium at repression
levels, could become exhausted or unavailable during
growth, thus leading to progressive PZn induction [12]
(Daniel Llull, Olivier Son, Nicolas Trémillon, Sandrine
Blanié, Julien Briffotaux, Sébastien Blugeon, Eric Morello,
Hélène Rogniaux, Olivier Danot, and Isabelle Poquet:
ZitR, a prototype of a new class of zinc responsive repres-
sors in Streptococcaceae, submitted). This could also
explain the differences in rNuc accumulation kinetics
according to the inducer concentration. When induced at
high EDTA concentration (at and above 500 μM), rNuc
rapidly accumulates (within 1 h) almost to its maximal
level, whereas at 100 μM EDTA, accumulation is much
slower and goes on for a longer time (Figure 2B). Interest-
ingly, rNuc levels of exponentially growing cells induced
by 100 μM EDTA for 1 h (Figure 2B) and of uninduced
cells at OD600=8 (Figure 2A) are similar, suggesting that
100 μM EDTA only has a weak inducing effect, in agree-
ment with the observation that it has only a slight, if any,
effect on cell growth (Figure 2B). The final rNuc level
after several hours of induction by 100 μM EDTA (Figure
2B) might result from an increased production rate due
to a higher biomass in a medium progressively depleted
of Zn2+.
The EDTA concentration for optimal induction is sig-
nificantly higher (more than 10 times) in both GM17v
and CDM medium than in SA, the medium we previously
used [12]. This is not surprising, as CDM and SA media
are highly different, notably for their micro-nutrient
composition (for example Mn2+ and Cu2+ are not added
to CDM in contrast to SA), and in particular for Zn2+
content, which is much higher (3 orders of magnitude) in
CDM than in SA [37,48]. Meanwhile, in both CDM and
GM17v medium, the same optimal inducer concentration
leads to a similar level of rNuc in the medium. As PZn
expression level was recently found to be inversely corre-
lated to extra-cellular Zn2+ concentration (Daniel Llull,
Olivier Son, Nicolas Trémillon, Sandrine Blanié, Julien
Briffotaux, Sébastien Blugeon, Eric Morello, Hélène
Rogniaux, Olivier Danot, and Isabelle Poquet: ZitR, a
prototype of a new class of zinc responsive repressors in
Streptococcaceae, submitted), this indicated that GM17v
and CDM media had similar Zn2+ contents.
Induction by EDTA at high concentration (1 mM) in
GM17v and CDM led to a growth defect of strain 918
(Figures 2A, 2B and 3A). However, this was not due to the
toxicity of EDTA per se, because of chelation of divalent
cations to detrimental levels and cell starvation, as 1 mM
EDTA specifically affected strain 918 but not the parental
strain MG1363 (under identical conditions in the absence
of antibiotic selection; data not shown). The specific
growth defect of strain 918 thus seems to result from the
presence of the pGTP_FZ301_NucB plasmid, and it is
tempting to speculate that it could be due to the meta-
bolic burden of secreted rNuc overproduction. In B. sub-
tilis, a similar inducer-dependent growth defect has
already been described for a strain over-expressing an
heterologous secreted protein: it was associated to a
secretion stress that was shown to lead to an adaptative
cell response including the induction of the CssRS regu-
lon [49-51]. This study should help define the conditions
for hitherto unexamined secretion stress in L. lactis.
In this study, under optimal induction conditions, an
rNuc production yield of 210 mg/L was reached. This
yield is comparable to the ones previously obtained for
staphylococcal nuclease forms produced in pH-regulated
fermentative cultures of L. lactis using inducible P170
promoter [52] or the constitutive Pusp45 promoter [38].
The efficiencies of the ZitR-regulated PZn  and NICE
expression systems were found to be comparable under
classical conditions [12]. All these comparisons indicate
that pGTP_FZ301 is an efficient tool and a useful alterna-
tive expression-secretion system in L. lactis.
rNuc could be purified from a lactococcal culture
medium in a single-step process. As L. lactis secretes few
native proteins, heterologous protein secretion greatly
simplifies downstream processing and purification.
Indeed, after a single purification using cationic exchange
resin, 85% of the rNuc protein was recovered pure at 99%
and fully active. For comparison, the cytoplasmic recom-
binant form of lysostaphin produced in L. lactis using the
NICE expression system was recovered to 80%, and was
only 90% pure after three steps of cation exchange chro-
matography [19]. Similarly, the staphylococcal nuclease R
produced by E. coli required two steps of metal chelating
affinity chromatography to be purified from a cell extract
[53].Thus secretion in L. lactis appears to simplify the
downstream purification process.
Conclusions
This study for the first time describes the use of the pro-
moter PZn in pH-regulated mini-reactors. Optimization
of induction conditions for nuclease production was rap-
idly achieved with the use of the pH controller LacMFTrémillon et al. Microbial Cell Factories 2010, 9:37
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and allowed to reach a yield of 210 mg/L. Nuclease pro-
duced by L. lactis was purified from the culture superna-
tant, providing a highly pure and active enzyme that
should be useful for removing RNA and DNA from cell
extracts. The fermentation, production and purification
processes that were set up for the production of staphylo-
coccal nuclease in L. lactis proved to be competitive, and
they should be used in the future for different heterolo-
gous proteins, like proteins of therapeutical value.
Methods
Bacterial strains and standard culture conditions
E. coli NEB 5-α (New England Biolabs, Ipswich, MA) was
grown at 37°C with 200-250 rpm shaking in reconstituted
Luria Bertani (LB) broth: 1% tryptone (Sigma, St Louis
MO), 5% yeast extract (Fluka, St Louis MO), 1% NaCl
(Fluka) resuspended in pure water, supplemented with
ampicillin at 100 μg/mL (Sigma) when necessary. Solid
media were prepared by adding technical agar (Invitro-
gen, Paisley UK) at a final concentration of 1.5% w/v. L.
lactis  MG1363 strain [54] and strain 918 [i. e.
MG1363(pGTP_FZ301_NucB)] were routinely grown at
30°C without shaking in rich M17 (Fluka) supplemented
with 1% glucose and with chloramphenicol 5 μg/mL
(Sigma) for plasmid selection in the case of strain 918.
A parallel fermentation system able to monitor 12 mini-
reactors
LacMF (Additional file 1, Figure S1) is a proportional,
integrative and derivative (PID) controller that allows
continuous pH monitoring and control of 12 simultane-
ous mini-reactors of 50 mL-1 L. pH is maintained at the
set point by adding 30% v/v NH4OH (Fluka) to the differ-
ent cultures, using a pump with twelve solenoid valves
(Additional file 1, Figure S1) that open sequentially and
for limited times. NH4OH neutralizes lactate produced
by fermentation, thus impeding medium acidification
and leading to prolonged exponential growth and a
higher biomass. Cultures are maintained at 30°C and con-
tinuously homogeneized by a magnetic stirrer (with 100-
150 rpm agitation). LacMF system allowed optimization
to be performed quickly, within two weeks and only 4
rounds of 12 independent experiments.
Fermentation and induction conditions in mini-reactors
Strain 918 was inoculated to an initial OD600 of 0.2 in 200
mL mini reactors and grown under standard fermenta-
tion conditions: at 30°C and pH 6.5 using LacMF. Two
different media: a chemically defined medium, CDM
[37], or a rich medium free of animal compounds,
GM17v, were used. GM17v contains 1% vegetable extract
(Fluka), 0.25% yeast extract (Fluka), 0.05% L-ascorbic acid
(Sigma), 1.9% Sodium glycero-phosphate (Sigma), 0.05%
MgSO4 (Fluka) and 5% glucose. When necessary, EDTA
0.5 M w/v (Sigma) was added to reach the indicated final
concentrations and induce rNuc expression. Samples
were harvested every hour to monitor bacterial growth
by spectrophotometrically measuring absorbance at 600
nm.
Plasmids
Plasmids used in this study are listed in Table 1 and clon-
ing strategy is shown in Figure 5. Sequence coding for
Exp4 signal peptide (SPExp4) was amplified from pLB145
[13] in a two-step PCR: using primers 1 and 2 (see Table 2
for primer sequences) for 5 cycles, and then primers 3
and 4 for 25 cycles. PCR product digested by RsrII and
BamHI was cloned into pGTPb_102a cloning vector
digested by the same enzymes, and the ligation was used
to transform E. coli NEB 5-α. pGTPb_SPExp4 from an
ampicillin resistant clone was verified by digestion and
sequencing. PZn zitR expression cassette was PCR-ampli-
Table 1: Plasmids used in this study.
Name Characteristics Reference
pLB145 CmR, pWV01 derivative carrying exp4SP-nucB gene fusion under the control of ZitR-regulated 
PZn promoter
[13]
pGTPb_102a AmpR, pFastBacHta (Invitrogen Paisley UK) derivative carrying an ORF for HFFT tag (His Flag 
FoldFold Flag Tev) [56-58]
This study
pGTPb_SPExp4 AmpR, pGTPb_102a derivative where the ORF for Exp4 signal peptide (SPExp4) has been 
cloned
This study
pGTPb_PZn zitR-SPExp4 AmpR, pGTPb_SPExp4 derivative where zitR is in operon with the ORF for SPExp4 under PZn 
control
This study
pGTP_FZ301 CmR, pLB145 derivative where a multi-cloning site has been cloned after the ORF for SPExp4 
(in operon with zitR under PZn control)
This study
pGTP_FZ301_NucB CmR, pGTP_FZ301 derivative where nucB ORF has been cloned leading to a gene fusion 
encoding SPExp4-NucB precursor and expressed under the control of ZitR-regulated PZn 
promoter
This studyTrémillon et al. Microbial Cell Factories 2010, 9:37
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fied from pLB145 using primers 5 and 6. PCR product
digested by AvaII was cloned into pGTPb_102a_SPExp4
previously digested by RsrII and dephosphorylated. Liga-
tion reaction was transformed into NEB 5-α competent
cells. pGTPb_PZn zitR-SPExp4 from an ampicillin-resistant
clone was verified by digestion and sequencing, revealing
three silent mutations in zitR sequence. PZn zitR SPExp4
expression and secretion cassette was PCR-amplified
from pGTPb_PZn zitR-SPExp4 using primers 7 and 8. PCR
product digested by BglII and EcoRI was ligated into
pLB145 previously digested by the same enzymes, and
the ligation was introduced into L. lactis MG1363 com-
petent cells. pGTP_FZ301 from a chloramphenicol-resis-
tant clone was verified by digestion and sequencing. nucB
ORF that encodes the mature secreted part (NucB or pro-
Nuc) of staphylococcal nuclease after signal peptide
cleavage [30] was PCR-amplified from pLB145 [13] using
primers 9 and 10. PCR product was digested by BamHI
and KpnI, cloned into pGTP_FZ301 previously digested
by BamHI and KpnI, and ligation was used to transform
MG1363. pGTP_FZ301_NucB plasmid extracted from a
chloramphenicol resistant clone was verified by digestion
and sequencing.
Restriction enzymes, T4 DNA ligase and Antartic
phosphatase (New england Biolabs, Ipswich, MA), high
fidelity Phusion™ DNA polymerase (Finnzymes, Espoo,
Finland) were used according to recommendations. DNA
purification kits were purchased from Macherey-Nagel
(Düren, Deutschland). Sequencing was performed by
Genome express (Meylan, France).
SDS-PAGE and protein quantification
Supernatants were separated from cell samples by cen-
trifugation and stored at -20°C. Protein samples were
analysed by SDS-PAGE using gradient (7.5-16.8%) gels
and Precision Plus Protein Standards was used for molec-
ular weight estimation (Biorad, California, USA). Com-
mercial BSA (Sigma) was used as a standard for protein
quantification. Gels were stained by Coomassie blue
G250 (Biorad), scanned (GS800 Calibrated densitometer,
Biorad) and analyzed using Image Quant (Amersham
Biosciences, Uppsala Sweden).
Nuclease purification
Culture supernatant was filtrated on 0.22 μm membrane,
diluted 15-fold in ultrapure water and loaded on a 10 mL
SP sepharose column (GE healthcare, Hillerod, Den-
mark). All purification steps were performed on an
AKTA purifier (GE healthcare). Column was washed with
20 volumes of washing buffer (15 mM sodium phosphate
buffer, 15 mM NaCl, pH 7.5). Nuclease was eluted by 10
volumes of elution buffer I (15 mM sodium phosphate
buffer, 500 mM NaCl, pH 7.5) and automatically collected
in fractions of 2.5 mL using FRAC910 (GE Healthcare).
Elution fractions were checked by SDS-PAGE, pooled
together and dialysed four times using a Spectra POR
dialysis membrane with a cut-off of 3.5 kDa (Spectrum,
Rancho Dominguez, CA) against 500 mL of dialysis buf-
fer (20 mM Tris buffer, 100 mM NaCl, 2 mM EDTA,
pH.7.5). Nuclease concentration was measured by densi-
tometry and the purified protein was stored at -20°C in
storage buffer (10 mM Tris buffer,, 50 mM NaCl, 1 mM
EDTA, 50% glycerol, pH 7.5).
Nuclease assay
Nuclease activity was assayed using a modified version of
a previously described method [22]. 10 μL of purified
nuclease protein was incubated in 500 μL of reaction buf-
fer (25 mM Tris-HCl, 10 mM CaCl2, 0.01% BSA (w/v),
0.1% Salmon sperm DNA pH 8.8) at 37°C for 30 min, and
the reaction was stopped by addition of 500 μL of 4% (v/
v) perchloric acid and left for 15 min on ice. In negative
controls, purified nuclease protein was added after the
addition of perchloric acid. Acid-insoluble nucleic acids
were sedimented by centrifugation for 10 min at 15000 g
at 4°C. DNA hydrolysis was determined by spectrophoto-
metrically measuring the absorbance of acid soluble poly-
nucleotides at 260 nm (One unit is defined as producing 1
μmole of acid soluble polynucleotides from DNA per
minute at pH 8.8 and 37°C [55]).
Additional material
Additional file 1 LacMF, a parallel fermentation control system. 12 lac-
tococcal cultures in mini-reactors of 200 mL can be made in parallel. They 
are maintained at 30°C and continously homogeneized by a magnetic stir-
rer ?), and pH is controlled by supplying a neutralizing agent, NH4OH, via a 
proportional, integrative and derivative (PID) controller. NH4OH is added to 
the mini-reactors by a pump (?) with twelve solenoid valves (?).
Table 2: Oligonucleotides used in this study.
Name Sequence
1 5' ACTCGGTCCGTACCTTAAGGAGATATAAAAATGA 3'
2 5' TTTTTTGGATCCAAACCTGCCAGTATCATCAGCAAATACA 
ACGGCT 3'
3 5' GAAAAAAACTCGGTCCGTACCTTAAGGAGA 3'
4 5' GTTTTTTTTTTGGATCCAAACCTGCCAGT 3'
5 5' GATATATATATGGTCCAGATCTTTGATCAAGGATCTGTC 3'
6 5' TCCTTAAGGTACGGACCGTCTTCATCGAAACTCTTCAGT 3'
7 5' AAAATGATAACCATCTCGCAA 3'
8 5' CTACAAATGTGGTATGGCTGAT 3'
9 5' TTTAAATTTAGGATCCGCATCACAAACAGATAACGG 3'
10 5' TATATATATAGGTACCTTATTGACCTGAATCAGCGT 3'Trémillon et al. Microbial Cell Factories 2010, 9:37
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